CHAMPIONS ONCOLOGY, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

CHAMPIONS ONCOLOGY, INC. reported Cash And Cash Equivalents At Carrying Value of $3.24 million for the year ending 2019.

  • CHAMPIONS ONCOLOGY, INC. showed an increase of +278.2% in Cash And Cash Equivalents At Carrying Value from 2018 to 2019.
  • This data is from CHAMPIONS ONCOLOGY, INC.'s annual report (Form 10-K), filed with the SEC on July 29, 2019.
  • XBRL data for this metric is available from 2010 to 2019 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2010 to 2019), CHAMPIONS ONCOLOGY, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 25.9%.
  • Historical annual values: Fiscal year 2019: $3.24 million | Fiscal year 2018: $856.0 thousand | Fiscal year 2017: $3.30 million | Fiscal year 2016: $2.59 million | Fiscal year 2015: $9.36 million | Fiscal year 2014: $5.89 million | Fiscal year 2013: $9.56 million | Fiscal year 2012: $4.75 million | Fiscal year 2011: $10.46 million | Fiscal year 2010: $2.57 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: